Coherus Oncology
Coherus Oncology

Coherus Oncology Information

Contact top employees from Coherus Oncology

Summary

Coherus Oncology is a public company that has been in the industry for 16 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the Chairman & CEO is occupied by Denny Lanfear. Its headquarters is located at Redwood City, California, USA. The number of employees ranges from 250 to 500. The annual revenue of Coherus Oncology varies between 100M and 500M. Total funding of the company - $244.8M. To connect with Coherus Oncology employee register on SignalHire.

Organization Website

coherus.com

Phone Number

1-800-794-5434

Industries

Headquarters Location

333 Twin Dolphin Drive, Suite 600, Redwood City, CA, 94065 US

Employees Size

200-500 employees

Specialties

biotechnology, Immuno-oncology

SIC Code

2836

DMA Code

San Francisco Bay Area

Founded

2010

Estimated Annual Revenue

$100M - 500M

Operating Status

Independent Company

Competitors

Founded
Type
Employees
Revenue
Funding
2005Public
Company
25 - 100 25.2M $76M
2010Privately
Held
25 - 100 4.4M $93.3M
2009Public
Company
1.0K - 5.0K 45M $634.9M
2013Public
Company
1.0K - 5.0K 106M $1.5B

Estimated Website Traffic

The chart shows a decline in traffic to the coherus.com website. In November, traffic decreased to 7668, compared to 8496 in the previous month. The highest traffic in 2025 was recorded in July, reaching 9212 visits.

Employees Turnover 4 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Number of employees by department
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at Coherus Oncology shows a diverse range of experience levels:
1% have been with the company for less than 1 year12% for 1–2 years20% for 3–4 years32% for 5–7 years21% for 8–10 years13% have over 11 years of service at Coherus Oncology
Ex-employees positions
In Company
In New Company
Contact top employees from Coherus Oncology
Nathalie Yanze
Senior Vice President, Regulatory Affairs
View
Hillary OKelly
Vice President, Clinical Operations
View
Sameer Goregaoker
Executive Vice President, Commercial
View
Vinson Lee
Vice President, Market Access
View
Ela Puchacz
VP, Process Sciences & Glycobiology
View
Jeremy Draper
Senior Medical Science Liaison
View
Andrea De Leon
Executive Administrative Assistant to C-Suite and Business Development Department
View
Kerrie Binno
Oncology Account Manager
View
Bob Abbassi
Director, Financial Planning and Analysis
View
Gilda Golshaian
Executive Director, Medical Information
View
Joanna Ly
Associate Director of Quality Systems
View
Liz Menzel
Human Resources Manager
View
Cole McIlwraith
Executive Director, Brand Lead
View
Jacob Copenheaver
Translational Data Science Intern
View
Noah Shen
Senior Director, Global Tax
View
Amisha Nair
Executive Director, Analytical Development and Quality Control
View
Rosalind Stenson
Principal Scientist
View
Vik Ram
Marketing Director
View
Kim Huebner
Senior Oncology Account Manager
View
Michelle Young
Senior Clinical Trial Manager
View
Jennifer Troiano
Retina Account Manager
View
Richard Stratton
Oncology Account Manager
View
Michael Ryan
Member Board of Directors
View
Rosh Dias
Chief Medical Officer
View
Jennifer Rubin
Sr. Director Market Acess & Reimbursement Services
View
VARUN
Senior Director Translational Medicine
View
Lindsey Thurman Castillano
Associate Director of Drug Product Manufacturing
View
Dawn Wise
Senior Director Product Development
View
Kerry Anderson
VP GxP Compliance
View

FAQ

Coherus Oncology operates in the Biotech industries. More details can be found on the official website: coherus.com.
The headquarters of Coherus Oncology are located in Redwood City, United States.
The current CEO of Coherus Oncology is Denny Lanfear
You can contact Coherus Oncology by phone at 1-800-794-5434.
Coherus Oncology currently employs 200-500 people.
Coherus Oncology's revenue is approximately 394.6M.
Well-known competitors of Coherus Oncology include XBiotech USA, Inc., Elcelyx Therapeutics Inc., Kite Pharma and Juno Therapeutics, Inc..
BACK TO TOP